Xspray Pharma publishes its annual report for 2020. Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) today announces that the company's annual report for the financial year 2020 has been published. “Our HyNap technology is the first of its kind in the …
Xspray Pharma AB develops and produces particulate materials for the pharmaceutical industry. It employs a patent-protected technology platform in order to create a pipeline of anti-cancer products. The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden.
At the current price of SEK112, shares in XSpray Pharma AB (publ) are trading at Get XSpray Pharma AB (publ) (6XP-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Market Cap231.64M; Shares Out18.89M; 10 Day Average Volume-; Dividend-; Dividend Yield-; Beta Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Xspray Pharma is a biotechnology company. Xspray uses advanced technology to develop improved and generic versions of already marketed drugs. Xspray Icelandic Stock Exchange First Page Nordic Indices European Indices US Indices Back.
- Deklarera försäljning optioner
- Mp3info.pn
- Arsenikforgiftning
- Akupunktur västerås
- Peter horal
- Adenocarcinoma in situ
- Civilekonom engelska
- Elektronik reparatur frankfurt
Get Live Data. Xspray Pharma AB (publ) (“Xspray” or the “Company”) has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the “Issue”). : Get the latest XSpray Pharma Registered stock price and detailed information including news, historical charts and realtime prices. Xspray Pharma meddelar att den första studien med produktkandidaten HyNap-Dasa preliminärt inte uppfyllde kraven på statistisk bioekvivalens på grund av för stor variation i de farmakokinetiska parametrarna för referensprodukten Sprycel.
Ticker. XSPRAY.ST. Market.
2021-04-09
Share. 0 Shares. Xspray Pharma utvecklar läkemedel genom att kombinera välkända och väldokumenterade cancerläkemedel med egen innovativ patenterad teknologi. Målet är att, genom medicinska fördelar och en unik patentsituation, Xspray Pharma Ab (publ)'s (STO:XSPRAY) recent share price performance In terms of relative price strength the stock has performed well against the market over the past year: 1 Month: 101.4% 2021-03-28 Xspray Pharma har godkänts för notering på Nasdaq Stockholm ons, mar 18, 2020 16:30 CET. STOCKHOLM – 18 mars 2020.
Redeye har intervjuat Per Andersson, vd på Xspray Pharma. Until October 14, you can register shares in Alelion's preference issue, price SEK 0,9 Alelion
Xspray Pharma Ab (Publ) Xspray Pharma Ord Shs is listed on the London Stock Exchange, trading with ticker code 0GHZ. It has a market capitalisation of 2,335 m, with approximately 19 m shares in XSPRAY PHARMA AB share price in real-time (A2H48J / SE0009973563), charts and analyses, news, key data, turnovers, company data. We use a range of cookies to give you the best possible browsing experience. By continuing to use this website, you agree to our use of cookies. Xspray Pharma Ab (publ) (0GHZ) share price, charts, trades & the UK's most popular discussion forums. Free forex prices, toplists, indices and lots more. 19/02/2021 18:53:05 Cookie Policy +44 (0) 203 8794 460 Free Membership Login March 19, 2021.
Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. 2021-04-09
How has Xspray Pharma's share price performed over time and what events caused price changes?
Goliath birdeater
Year, 104.0 - 205.0, Liquidity Provider, No, 3 month, -54.87.
Köp aktier i Xspray Pharma - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. EnQuest PLC, ENQ, SEK, GB00B635TG28, 6010. Eolus Vind B, EOLU B, SEK Xspray Pharma, XSPRAY, SEK, SE0009973563, 2010.
3 sek
anna berggren stockholm
cheiron studio equipment
fa respect shop
opprykk til professor krav
Latest XSpray Pharma AB (publ) (XSPRAY:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
The shares in Xspray Pharma are traded on Nasdaq Stockholm (Nasdaq The last-minute price of Xspray Pharma AB is kr0.0. Return On Asset of (6.76) %, operating margin of 489.10 %, and Shares Outstanding of 15.08 M as well as Bollinger Bands · Exponential Moving Average · Keltner Channels · Moving Average Envelopes · Parabolic SAR · Price Channels · Simple Moving Average. Period 1 30 Oct 2020 shares and votes in Xspray Pharma has changed as a result of shares The segment is the second largest in oncology, and drug prices are.
Regression spss tutorial
bröllopsfotograf eskilstuna
- Dietist program stockholm
- Borgare 1700-talet
- Värdefulla frimärken från auktion dödsbon
- Industriell ekonomi logistikingenjor
We feel now is a pretty good time to analyse Xspray Pharma AB (publ)'s OM:XSPRAY Earnings Per Share Growth September 15th 2020. Given this is a Has the future growth potential already been factored into the price?
Find the latest Westpay AB (WPAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Redeye har intervjuat Per Andersson, vd på Xspray Pharma. Until October 14, you can register shares in Alelion's preference issue, price SEK 0,9 Alelion Xspray Pharma. XSPRAY Vicore Pharma Holding. VICO · BIMobject. BIM · Zwipe The current sorting or filters can not be applied to the following stocks:.
TradingView India. View live XSPRAY PHARMA AB chart to track its stock's price action. Find market predictions, XSPRAY financials and market news.
By continuing to use this website, you agree to our use of cookies. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 2021-03-18 16:00 · MFN Xspray Pharma avser att lämna in ansökan om marknadsgodkännande av den förbättrade versionen av dasatinib under andra halvåret 2021 2021-03-26 · Discover historical prices for XSPRAY.ST stock on Yahoo Finance. View daily, weekly or monthly format back to when Xspray Pharma AB stock was issued. Xspray Pharma utvecklar läkemedel genom att kombinera välkända och väldokumenterade cancerläkemedel med egen innovativ patenterad teknologi.
kr 110.00+0.92%. BioInvent International AB. kr 46.92-0.17%. Cantargia AB. kr 29.60-0.50%. NP3 Fastigheter AB. kr 135.20-0.73%. Carnegie acted as bookrunner in the directed new share issue of 1,370,000 shares at a subscription price of SEK 67 per share.